Episode
Dr. Joel Braunstein on Innovating with Integrity (Re-Air)
- Podcast
- Chief Influencer®
- Published
- Mar 25, 2026
- Duration seconds
- 2531
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/6c4a9686
Actions
POST https://stenobird.com/v1/public/podcasts/chief-influencer-6371343/episodes/dr-joel-braunstein-on-innovating-with-integrity-re-air/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/chief-influencer-6371343/dr-joel-braunstein-on-innovating-with-integrity-re-air.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Today, we’re revisiting our conversation with Dr. Joel Braunstein, who is the CEO and Co-Founder of C₂N Diagnostics, a company dedicated to the development and commercialization of diagnostics for Alzheimer's disease and related neurodegenerative conditions. Dr. Braunstein offers insights from his extensive experience in the healthcare sector, detailing his academic journey and highlighting the pivotal role played by C₂N in advancing Alzheimer's diagnostics over the past two decades. Engaging in conversation with host Anthony Shop, Dr. Braunstein traces the evolution of Alzheimer's disease diagnosis, from conventional methods to the groundbreaking blood test pioneered by C₂N, which provides a more accessible and less invasive diagnostic alternative. Throughout the discussion, Dr. Braunstein underscores the importance of early and accurate diagnosis in Alzheimer's disease management, emphasizing its potential for treatment intervention and its profound impact on patients and their families. He also addresses the challenges inherent in navigating the healthcare industry and stresses the significance of stakeholder engagement. Furthermore, Dr. Braunstein reflects on the complexities of communicating scientific advancements to diverse audiences, including patients, clinicians, and policymakers, highlighting the delicate balance between ethical responsibility and the imperative of raising disease awareness effectively. Takeaways: Leaders should commit to relentless pursuit in their fields, especially when facing long-term challenges. For instance, Braunstein's dedication to Alzheimer's research underscores the importance of steadfast commitment to making a difference. Be transparent and evidence-driven in your communication, especially when introducing new technologies or i…